COVID-19 vaccine and boosted immunity: Nothing ad interim to do?

Today, Coronavirus Disease 2019 (COVID-19) is a global public health emergency and vaccination measures to counter its diffusion are deemed necessary. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiological agent of the disease, unleashes a T-helper 2 immune response in those p...

Descripción completa

Detalles Bibliográficos
Autores principales: Roncati, Luca, Vadalà, Maria, Corazzari, Veronica, Palmieri, Beniamino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546174/
https://www.ncbi.nlm.nih.gov/pubmed/33071005
http://dx.doi.org/10.1016/j.vaccine.2020.10.013
_version_ 1783592176886743040
author Roncati, Luca
Vadalà, Maria
Corazzari, Veronica
Palmieri, Beniamino
author_facet Roncati, Luca
Vadalà, Maria
Corazzari, Veronica
Palmieri, Beniamino
author_sort Roncati, Luca
collection PubMed
description Today, Coronavirus Disease 2019 (COVID-19) is a global public health emergency and vaccination measures to counter its diffusion are deemed necessary. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiological agent of the disease, unleashes a T-helper 2 immune response in those patients requiring intensive care. Here, we illustrate the immunological mechanism to train the immune system towards a more effective and less symptomatic T-helper 1 immune response, to be exploited against SARS-CoV-2.
format Online
Article
Text
id pubmed-7546174
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-75461742020-10-13 COVID-19 vaccine and boosted immunity: Nothing ad interim to do? Roncati, Luca Vadalà, Maria Corazzari, Veronica Palmieri, Beniamino Vaccine Commentary Today, Coronavirus Disease 2019 (COVID-19) is a global public health emergency and vaccination measures to counter its diffusion are deemed necessary. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2), the etiological agent of the disease, unleashes a T-helper 2 immune response in those patients requiring intensive care. Here, we illustrate the immunological mechanism to train the immune system towards a more effective and less symptomatic T-helper 1 immune response, to be exploited against SARS-CoV-2. Elsevier Ltd. 2020-11-10 2020-10-09 /pmc/articles/PMC7546174/ /pubmed/33071005 http://dx.doi.org/10.1016/j.vaccine.2020.10.013 Text en © 2020 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Commentary
Roncati, Luca
Vadalà, Maria
Corazzari, Veronica
Palmieri, Beniamino
COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
title COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
title_full COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
title_fullStr COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
title_full_unstemmed COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
title_short COVID-19 vaccine and boosted immunity: Nothing ad interim to do?
title_sort covid-19 vaccine and boosted immunity: nothing ad interim to do?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7546174/
https://www.ncbi.nlm.nih.gov/pubmed/33071005
http://dx.doi.org/10.1016/j.vaccine.2020.10.013
work_keys_str_mv AT roncatiluca covid19vaccineandboostedimmunitynothingadinterimtodo
AT vadalamaria covid19vaccineandboostedimmunitynothingadinterimtodo
AT corazzariveronica covid19vaccineandboostedimmunitynothingadinterimtodo
AT palmieribeniamino covid19vaccineandboostedimmunitynothingadinterimtodo

Ejemplares similares